OM

Opaleye Management Portfolio holdings

AUM $707M
1-Year Est. Return 67.55%
This Quarter Est. Return
1 Year Est. Return
+67.55%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$600M
AUM Growth
+$162M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$17.2M
2
+$16.4M
3
+$13.7M
4
DNA icon
Ginkgo Bioworks
DNA
+$6.68M
5
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$3.56M

Top Sells

1
+$10.5M
2
+$7.26M
3
+$7.19M
4
CYTK icon
Cytokinetics
CYTK
+$6.5M
5
NTLA icon
Intellia Therapeutics
NTLA
+$4.88M

Sector Composition

1 Healthcare 98.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$3.98M 0.66%
75,300
-123,200
27
$3.71M 0.62%
3,665,010
-244,990
28
$3.56M 0.59%
+967,000
29
$3.08M 0.51%
1,681,154
-623,108
30
$2.26M 0.38%
+466,563
31
$2.24M 0.37%
112,500
-527,500
32
$2.08M 0.35%
800,000
+600,000
33
$1.93M 0.32%
69,750
-13,750
34
$1.57M 0.26%
2,407,600
-372,400
35
$1.56M 0.26%
480,000
-120,000
36
$1.53M 0.26%
+179,200
37
$1.43M 0.24%
+275,000
38
$1.41M 0.23%
654,943
-210,500
39
$920K 0.15%
12,571
40
$840K 0.14%
535,000
-940,000
41
$833K 0.14%
375,000
42
$285K 0.05%
+110,571
43
– –
-50,400
44
– –
-205,000
45
– –
-345,750
46
– –
-285,000
47
– –
-897,000
48
– –
-95,000
49
– –
-1,875,000
50
– –
-218,000
1
2
3